Market Sectors: Pharmaceuticals

Featured Articles

Sun: Settles on Taro with Israeli SC verdict
The Israeli SC rejected an appeal by Taro Pharmaceutical to block Sun Pharmaceutical from raising its stake in the company.
Sun: Settles on Taro with Israeli SC verdict Comment

Sun: Settles on Taro with Israeli SC verdict

The Israeli SC rejected an appeal by Taro Pharmaceutical to block Sun Pharmaceutical from raising its stake in the company.
Vertex: Hepatitis C drug can help patients Comment

Vertex: Hepatitis C drug can help patients

Vertex Pharmaceuticals Inc. has said that its Hepatitis C drug ‘telaprevir’ can greatly benefit patients.
Avandia: To be pulled out from market Comment

Avandia: To be pulled out from market

British Medical Journal wants Avandia to be withdrawn from the market.
Sun Pharma: Gets FDA approval for new drug Comment

Sun Pharma: Gets FDA approval for new drug

Sun Pharma said it has received FDA approval for their hyperactivity disorder drug.
Sun Pharma: Gets FDA approval for new drug Comment

Sun Pharma: Gets FDA approval for new drug

Sun Pharma said it has received FDA approval for their hyperactivity disorder drug.
Shasun: Enters into a JV with Nanoparticle Biochem Comment

Shasun: Enters into a JV with Nanoparticle Biochem

Chennai based Shasun Pharmaceuticals Ltd. has entered into a joint venture with U.S. based Nanoparticle Biochem Inc.
Haw Par Corporation Ltd : Competence with the Counter Product Comment

Haw Par Corporation Ltd : Competence with the Counter Product

Singapore based Haw Par Corporation Ltd, the maker of Tiger Balm, failed to adequately test its healthcare unit's over-the-counter products, the U.S. drug regulator said.
Glenmark and Sepracor: Into the License Agreement Comment

Glenmark and Sepracor: Into the License Agreement

Sepracor has entered into a settlement and licence agreement with Glenmark Generics, USA, Glenmark Generics and Glenmark Pharmaceuticals.
Jazz Pharmaceuticals Inc: Fall in shares Comment

Jazz Pharmaceuticals Inc: Fall in shares

Shares of Jazz Pharmaceuticals Inc. fall after a negative panel vote by FDA experts.
Aspen Pharmacare buys Herron Pharmaceuticals Comment

Aspen Pharmacare buys Herron Pharmaceuticals

South Africa-based Aspen Pharmacare is set to acquire the Herron range as part of a $900 million deal.